Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening

被引:2
|
作者
Liebermann, Erica [1 ,2 ]
Fontenot, Holly B. [3 ]
Lim, Eunjung [4 ]
Matsunaga, Masako [4 ]
Zimet, Gregory [5 ]
Allen, Jennifer D. [6 ]
机构
[1] Univ Rhode Isl, Coll Nursing, RINEC, 350 Eddy St, Providence, RI 02903 USA
[2] Univ Rhode Isl, Coll Nursing, Providence, RI USA
[3] Univ Hawaii Manoa, Nancy Atmospera Walch Sch Nursing, Honolulu, HI USA
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
[6] Tufts Univ, Sch Arts & Sci, Dept Community Hlth, Medford, MA USA
关键词
HEALTH-CARE PROVIDERS; WOMEN; ACCEPTABILITY; PARTICIPATION; PERSPECTIVES;
D O I
10.1016/j.jogn.2023.05.114
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To examine associations among women's preferred locations for human papillomavirus (HPV) self-sampling in relation to their demographic, social, and health characteristics and their perceived benefits and concerns regarding this procedure.Design: Cross-sectional, descriptive survey.Setting: Online distribution between March 2022 and April 2022.Participants: People who were assigned female sex at birth and were eligible for cervical cancer screening (N = 367: cis-gender women, n = 364; another gender identity, n = 3).Methods: We used quota sampling to obtain a racially and ethnically diverse sample. We conducted bivariate analyses to examine differences in participants' preferred locations for HPV self-sampling by sociodemographic and health characteristics. We used a multinomial logistic regression model to examine the associations between preferred HPV self-sampling location, characteristics of participants, and perceived benefits and concerns regarding this procedure.Results: In our sample, 43% (n = 158) of participants preferred HPV self-sampling at the office of a health care provider, 50% (n = 182) preferred HPV self-sampling anywhere (office or home), and 7% (n = 27) did not feel comfortable with HPV self-sampling anywhere. Participants 39 to 45 years of age were more likely to prefer HPV self sampling anywhere (office or home) than participants 27 to 32 years of age, OR = 2.47, 95% confidence interval (CI) [1.21, 5.06]. Participants who preferred HPV self-sampling anywhere perceived greater benefit related to limited geographic access to a clinic compared to those who preferred office only, OR = 1.82, 95% CI [1.08, 3.07]. Participants who preferred HPV self-sampling anywhere had less concern related to performing the procedure accurately than those who preferred office only, OR = 0.44, 95% CI [0.31, 0.62].Conclusion: HPV self-sampling is an alternative strategy to increase cervical cancer screening. As providers consider implementation of HPV self-sampling, our findings suggest that office and home-based collection strategies should be considered to increase access to cervical cancer screening.
引用
收藏
页码:364 / 373
页数:10
相关论文
共 50 条
  • [41] Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly
    Rebolj, Matejka
    Sargent, Alexandra
    Njor, Sisse Helle
    Cuschieri, Kate
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (01) : 8 - 19
  • [43] High-Grade Cervical Intraepithelial Neoplasia in Human Papillomavirus Self-sampling of Screening Non-attenders
    Lam, J. U. H.
    Elfstrom, K. M.
    Ejegod, D. M.
    Pedersen, H.
    Rygaard, C.
    Rebolj, M.
    Lynge, E.
    Juul, K. E.
    Kjaer, S. K.
    Dillner, J.
    Bonde, J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (05) : 280 - 281
  • [44] Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits
    Malone, Colin
    Tiro, Jasmin A.
    Buist, Diana S. M.
    Beatty, Tara
    Lin, John
    Kimbel, Kilian
    Gao, Hongyuan
    Thayer, Chris
    Miglioretti, Diana L.
    Winer, Rachel L.
    JOURNAL OF MEDICAL SCREENING, 2020, 27 (03) : 146 - 156
  • [45] Self-sampling for HPV testing in cervical cancer screening: A scoping review
    Colonetti, Tamy
    Uggioni, Maria Laura Rodrigues
    dos Santos, Ana Luiza Meller
    Uggioni, Naiade Michels
    Elibio, Laura Uggioni
    Balbinot, Eduarda Leticia
    Grande, Antonio Jose
    Rosa, Maria Ines
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 296 : 20 - 51
  • [46] Co-creation of human papillomavirus self-sampling delivery strategies for cervical cancer screening in rural Zimbabwe: nominal group technique
    Dzobo, Mathias
    Dzinamarira, Tafadzwa
    Murewanhema, Grant
    Chishapira, Tatenda
    Mandishora, Racheal S. Dube
    Fitzpatrick, Megan
    Mashamba-Thompson, Tivani
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [47] Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Maori and Pasifika women: a pilot study
    Brewer, Naomi
    Foliaki, Sunia
    Bromhead, Collette
    Viliamu-Amusia, Ioana
    Pelefoti-Gibson, Litia
    Jones, Tegan
    Pearce, Neil
    Potter, John D.
    Douwes, Jeroen
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1497) : 21 - 31
  • [48] Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening
    Dareng, Eileen O.
    Jedy-Agba, Elima
    Bamisaye, Patience
    Modibbo, Fatima Isa
    Oyeneyin, Lawal O.
    Adewole, Ayodele S.
    Olaniyan, Olayinka B.
    Dakum, Patrick S.
    Pharoah, Paul D.
    Adebamowo, Clement A.
    PLOS ONE, 2015, 10 (11):
  • [49] Is It Time to Introduce HPV Self-Sampling for Primary Cervical Cancer Screening?
    Petignat, Patrick
    Vassilakos, Pierre
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (03): : 166 - 167
  • [50] Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia
    Veerus, Piret
    Hallik, Reeli
    Janes, Jaak
    Joers, Kai
    Paapsi, Keiu
    Laidra, Kaia
    Innos, Kaire
    JOURNAL OF MEDICAL SCREENING, 2022, 29 (01) : 53 - 60